Evidence map›Paper›PMID 24900579›Full record

ArticleACS medicinal chemistry letters2013

Nexus between protein-ligand affinity rank-ordering, biophysical approaches, and drug discovery.

M Ashley Spies

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

M Ashley SpiesDepartment of Biochemistry, Carver College of Medicine, and Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa , 115 South Grand Avenue, Iowa City, Iowa 52242, United States.

Funding

Exploiting Enzyme Plasticity in Drug Discovery: application to glutamate racemaseR01GM097373 · NIGMS · UNIVERSITY OF IOWA · PI SPIES, MICHAEL ASHLEY · 2012 to 2020
$2.7M
NIGMS NIH HHS R01 GM097373
6 · The paper itself

Abstract

The confluence of computational and biophysical methods to accurately rank-order the binding affinities of small molecules and determine structures of macromolecular complexes is a potentially transformative advance in the work flow of drug discovery. This viewpoint explores the impact that advanced computational methods may have on the efficacy of small molecule drug discovery and optimization, particularly with respect to emerging fragment-based methods.

Identifiers

PMID24900579
PMCPMC4027140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.